FIRM FIXED PRICENO SET ASIDE USED.

ADAPTIVE BIOTECHNOLOGIES CORPORATION - CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS.

PIID: HT001425P0034
Signed Date: Nov 26, 2025Effective Date: Feb 28, 2025End Date: Closed on Feb 27, 2026

Key Details

Dollars Obligated
$44,850
Base & All Options
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Health Agency
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
COMPETED UNDER SAP
Number of Offers
1
Place of Performance
BETHESDA, MD, 208895600, CD-MD-08

Description

CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS.

Contractor Information

UEI: DMW5BNQ331K9
CAGE Code: 5SRQ2
Location: SEATTLE, WA

Stay Updated

Get notified about new opportunities matching your interests.

Related